SUBSCRIBE
SUBSCRIBE
News   Drug Development

ArQule, Inc. Presents Three Studies at American Association for Cancer Research 100th Annual Meeting 2009

April 20, 2009 | 
1 min read
WOBURN, Mass.--(BUSINESS WIRE)--ArQule, Inc. (NASDAQ: ARQL) today announced that the Company is presenting three studies at the AACR (American Association for Cancer Research) 100th Annual Meeting 2009, April 18-22, 2009 in Denver, Colorado.
Preclinical
MORE ON THIS TOPIC
Opportunity of winning. man sees a illuminated trophy door. vector
autoimmune disease
Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren’s study
September 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Human kidney made out of lines. Medical Concept. 3D Rendering.
Kidney disease
Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
September 23, 2026
 · 
2 min read
 · 
Annalee Armstrong
Microscope icon. Molecule and communication background. Connected lines with dots.
Deals
Novartis bets up to $900M for radioligand therapy from China’s BoomRay
September 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Close up shot red darts arrows in the target center on dark blue sky background. Business target or goal success and winner concept.
ALS
Ionis-Otsuka offer ‘groundbreaking’ improvement in function and survival for genetic type of ALS
September 23, 2026
 · 
4 min read
 · 
Heather McKenzie